Topic

Cigna

A collection of 1134 issues

How to Get Zolgensma Covered by Cigna in New Jersey: Complete Guide to Prior Authorization, Appeals, and IHCAP External Review

Answer Box: Getting Zolgensma Covered by Cigna in New Jersey Cigna covers Zolgensma (onasemnogene abeparvovec) for children under 24 months with genetically confirmed spinal muscular atrophy (SMA) through prior authorization. The fastest path: (1) Gather genetic test results showing bi-allelic SMN1 mutations and anti-AAV9 antibody titer ≤1:50, (2) Submit

How to Get Bylvay (odevixibat) Covered by Cigna in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Bylvay (odevixibat) Covered by Cigna in New Jersey Eligibility: Bylvay requires prior authorization from Cigna for PFIC (≥3 months) or Alagille syndrome (≥12 months) with documented moderate-to-severe pruritus and failed conventional therapies. Fastest path: Submit complete PA through Express Scripts portal with genetic testing, specialist consultation, and

Getting Pomalyst (Pomalidomide) Covered by Cigna in Texas: Prior Authorization, Appeals, and State Protection Guide

Answer Box: Your Fastest Path to Coverage Getting Pomalyst (pomalidomide) covered by Cigna in Texas requires prior authorization with proof of multiple myeloma diagnosis, failure of lenalidomide and a proteasome inhibitor, and REMS enrollment. If denied, you have 180 days to appeal internally, then can request Texas Independent Review Organization

How to Get Rylaze Covered by Cigna in Florida: Prior Authorization Forms, Appeals, and Contact Numbers

Answer Box: Getting Rylaze Approved by Cigna in Florida Rylaze requires prior authorization from Cigna for patients ≥1 month with ALL/LBL who experienced Grade 3+ hypersensitivity to E. coli asparaginase. Fastest approval path: Submit the Cigna Rylaze PA form with documented hypersensitivity records via CoverMyMeds or fax to 855-840-1678.

Renewing Strensiq (Asfotase Alfa) Approval with Cigna in Michigan: Timeline, Documentation, and What to Prepare

Answer Box: Renewing Your Strensiq Coverage with Cigna Cigna requires annual prior authorization renewal for Strensiq (asfotase alfa) with detailed documentation of continued medical necessity. Start the renewal process 6-8 weeks before your current PA expires to avoid treatment gaps. You'll need updated clinical notes, recent lab results

Getting Zanzalintinib (XL092) Covered by Cigna in Texas: Complete Coding, Appeals, and Prior Authorization Guide

Answer Box: Getting Zanzalintinib (XL092) Covered by Cigna in Texas Zanzalintinib (XL092) is investigational and typically denied by Cigna, but coverage is possible through prior authorization and appeals. Start with your oncologist submitting a detailed PA request using ICD-10 codes specific to your cancer type and HCPCS code J3490. If

How to Get iLink® Corneal Cross-Linking Covered by Cigna in Texas: Prior Authorization, Appeals, and Cost-Saving Strategies

Answer Box: Getting iLink® Covered by Cigna in Texas Cigna covers iLink® corneal cross-linking for progressive keratoconus when you meet specific criteria: age 14-65, documented disease progression, and use of the FDA-approved epithelium-off protocol only. Your fastest path: Have your ophthalmologist submit prior authorization with serial topography showing progression (≥1

How to Get Isturisa (Osilodrostat) Covered by Cigna in North Carolina: Complete Prior Authorization Guide

Answer Box: Getting Isturisa (Osilodrostat) Covered by Cigna in North Carolina Eligibility: Cigna covers Isturisa for adult Cushing's disease when surgery isn't an option or wasn't curative, prescribed by an endocrinologist with documented abnormal cortisol tests. Fastest path: Submit prior authorization through Cigna'

How to Get Daybue (Trofinetide) Covered by Cigna in Virginia: Complete PA Guide with Forms and Appeal Timeline

Answer Box: Getting Daybue (Trofinetide) Covered by Cigna in Virginia Cigna requires prior authorization for Daybue (trofinetide) through their specialty pharmacy Accredo. Key requirements: confirmed Rett syndrome diagnosis with MECP2 genetic testing, patient age ≥2 years, and specialist prescriber (neurologist/geneticist). If denied, you have 180 days to file an

Get Xospata (Gilteritinib) Approved by Cigna in Washington: Prior Authorization, Appeals & Alternatives

Answer Box: Getting Xospata (Gilteritinib) Covered by Cigna in Washington Eligibility: Xospata requires prior authorization from Cigna for adults with relapsed/refractory AML who have FLT3-mutated disease confirmed by an FDA-approved test. Fastest path: Have your hematologist submit clinical documentation showing FLT3 mutation positivity, prior therapy failures, and medical necessity